Patent Ductus Arteriosus
📧 Sign up to get email alerts when something new happens for Patent Ductus Arteriosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2019-02-04Clinical Trial Update: Emergency/Compassionate Use - AMPLATZER Duct Occluder
This clinical trial update notes that the emergency/compassionate use program for the AMPLATZER Duct Occluder has become no longer available…
-
CLINICAL_TRIALS withdrawal · 2015-09-02Clinical Trial Update: Comparing Ibuprofen And Indomethacin For The Treatment Of The Patent Ductus Arteriosus in Very Premature Babies [Phase 4]
A Phase 4 clinical trial comparing ibuprofen versus indomethacin for the treatment of patent ductus arteriosus in very preterm infants has b…
-
CLINICAL_TRIALS withdrawal · 2015-01-26Clinical Trial Update: Brain, Gut and Kidney Blood Flow During Medical Closure of PDA
The clinical trial NCT00554307 evaluating brain, gut, and kidney blood flow during pharmacologic closure of patent ductus arteriosus has bee…
-
CLINICAL_TRIALS withdrawal · 2013-01-16Clinical Trial Update: Impact of Maternal-infant Therapeutics on Safety, Mortality, and Disability
A Duke University-sponsored clinical trial evaluating maternal-infant therapeutics for safety, mortality, and disability has been withdrawn;…
-
CLINICAL_TRIALS withdrawal · 2012-06-07Clinical Trial Update: Second Course of Therapy for Resistant Patent Ductus Arteriosus (PDA) [Phase 2]
This update notes that a Phase 2 trial evaluating a second course of therapy for resistant patent ductus arteriosus has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.